Get the Stockscreener App
93.15
1.37%
1.26
After Hours:
92.98
-0.17
-0.18%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $93.15, with a volume of 8.90M.
It is up +1.37% in the last 24 hours and up +19.90% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$91.89
Open:
$90.98
24h Volume:
8.90M
Relative Volume:
1.28
Market Cap:
$75.08B
Revenue:
$20.38B
Net Income/Loss:
$2.26B
P/E Ratio:
35.53
EPS:
2.6214
Net Cash Flow:
$3.63B
1W Performance:
+8.62%
1M Performance:
+19.90%
6M Performance:
+11.54%
1Y Performance:
+7.03%
1-Day Range:
$90.98
$93.33
1-Week Range:
$84.70
$93.33
52-Week Range:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
93.15 | 74.07B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
PG
Procter Gamble Co
|
155.32 | 356.01B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
69.15 | 149.97B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
116.27 | 42.80B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KVUE
Kenvue Inc
|
17.59 | 33.30B | 15.01B | 1.43B | 1.63B | 0.744 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-07-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
This Once-Sleepy Consumer Staples Stock Is Beating the S&P 500 by 8-to-1 in 2026: Should You Buy? - Finviz
Colgate-Palmolive’s 2025 Earnings: Solid Profits and Clear Path to Net Zero by 2040 - CarbonCredits.com
Colgate-Palmolive (CL) Receives Mixed Analyst Rating with Target Price Increase | CL Stock News - GuruFocus
Colgate-Palmolive Forecasts Upbeat Annual Sales As Essential Spending Holds Firm - checkout.ie
Colgate-Palmolive shares jump following strong 2025 results - The Grocer
A Look At Colgate-Palmolive (CL) Valuation After Q4 Earnings Beat And 2030 Growth Plan Unveiling - simplywall.st
Colgate-Palmolive (NYSE:CL) Gains Attention In Consumer Staples S&P 500 - Kalkine Media
Colgate stock pops after hours as Wall Street lifts targets — what’s next for NYSE:CL - TechStock²
Colgate-Palmolive (CL) Receives Maintained Rating with Price Tar - GuruFocus
Jefferies Financial Group Issues Positive Forecast for Colgate-Palmolive (NYSE:CL) Stock Price - MarketBeat
Citigroup Raises Price Target for Colgate-Palmolive (CL) to $105 - GuruFocus
Colgate-Palmolive (CL) Price Target Raised by JP Morgan to $97 | - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Raised to $97.00 - MarketBeat
Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Colgate-Palmolive stock rating reiterated at Buy by UBS on strong Q4 - Investing.com Australia
Wells Fargo Maintains Equal-Weight on Colgate-Palmolive (CL), Ra - GuruFocus
Evercore ISI Group Raises Price Target for CL, Maintains Outperf - GuruFocus
Colgate-Palmolive (CL): Piper Sandler Raises Price Target to $96 - GuruFocus
Why Colgate-Palmolive is moving talent across borders to develop leaders - Yahoo Finance UK
Colgate-Palmolive (NYSE:CL) Price Target Raised to $100.00 at Bank of America - MarketBeat
Colgate-Palmolive (CL) Price Target Raised by Morgan Stanley | C - GuruFocus
Colgate-Palmolive (CL) Sees Analyst Rating Maintained and Price Target Raised | CL Stock News - GuruFocus
Deutsche Bank Maintains 'Hold' on CL, Raises Price Target to $90 - GuruFocus
Evercore ISI raises Colgate-Palmolive stock price target to $100 on growth momentum - Investing.com Nigeria
Morgan Stanley raises Colgate-Palmolive stock price target to $100 on strong emerging markets growth - Investing.com
Beyond The Numbers: 10 Analysts Discuss Colgate-Palmolive Stock - Benzinga
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Are Wall Street Analysts Bullish on Colgate-Palmolive Stock? - inkl
Colgate-Palmolive stock price target raised to $94 from $86 at Wells Fargo - Investing.com India
Colgate-Palmolive stock price target raised to $96 from $86 at TD Cowen By Investing.com - Investing.com South Africa
Colgate-Palmolive Company (CL) PT Raised to $100 at Morgan Stanley, 'Top HPC Pick' - StreetInsider
Colgate-Palmolive stock price target raised to $96 from $86 at TD Cowen - Investing.com India
Colgate-Palmolive Company (CL) PT Raised to $96 at TD Cowen - StreetInsider
Hold Colgate Palmolive; target of Rs 2319: Prabhudas Lilladher - Moneycontrol
Colgate-Palmolive reports full-year 2025 sales growth as impairment weighs on GAAP earnings - Global Cosmetics News
Colgate Palmolive (CL) One Off US$1.0b Charge Tests Premium P/E Narrative - simplywall.st
The Truth About Colgate-Palmolive (India): Is This ‘Boring’ Stock Actually a Silent Money Machin - AD HOC NEWS
Palmolive Soap Review: Why This Humble Hand Wash Is Quietly Taking Over European Bathrooms - AD HOC NEWS
Colgate-Palmolive’s 2030 Plan Tests Growth, Productivity And Valuation Optimism - Yahoo Finance UK
Colgate-Palmolive’s 2030 Plan Weighs Latin America Rebound And Pet Nutrition - simplywall.st
Colgate-Palmolive Company (NYSE:CL) Q4 2025 Earnings Call Transcript - Insider Monkey
Colgate-Palmolive Q4 2025 Results: Adjusted EPS $0.95, Revenue $5.23BNews and Statistics - IndexBox
Colgate-Palmolive (CL) Climbs 6% on Upbeat Outlook Despite Headwinds - Insider Monkey
Colgate-Palmolive (CL) Faces Market Uncertainty; Stock Rises Ami - GuruFocus
Colgate-Palmolive Co (CL) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Colgate-Palmolive Q4 Organic Sales Rise 2.2%, Beating Estimates - GuruFocus
Colgate-Palmolive (NYSE:CL) Momentum Builds Across Russell 1000 Index Categories - Kalkine Media
Colgate-Palmolive’s Q4 Loss and Bold 2026 Outlook Could Be A Game Changer For Colgate-Palmolive (CL) - simplywall.st
Colgate-Palmolive Q4 2025 slides: Organic sales growth accelerates, new strategy unveiled - Investing.com Nigeria
Colgate-Palmolive (CL) Q4 2025 Earnings Transcript - AOL.com
Colgate-Palmolive's Core Strength Lifts Q4 Results - Benzinga
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):